Literature DB >> 7516779

Interaction between bacteria and the lumenal bladder surface: modulation by pentosan polysulfate, an experimental and theoretical approach with clinical implication.

D H Schamhart1, E C de Boer, K H Kurth.   

Abstract

An attempt was made to interpret bacterial adsorption to the lumenal surface of the urinary bladder wall under normal and pathological conditions according to the DLVO theory of lyophobic colloid stability, which describes the interaction between a bacterium and the bladder-wall surfaces as a balance of attraction and repulsion forces. Computer modeling suggested that a decrease in the surface potential of the bladder wall may well explain an increased bacterial adsorption, possibly associated with bacterial cystitis. With the intent of preventing bacterial adsorption, treatment of bacterial cystitis by intravesical instillation of pentosan polysulfate (PPS) was evaluated. PPS is a polysaccharide with high affinity (4 +/- 2 mg/bladder) to the bladder. The attachment of PPS strongly depends on the intrinsic properties of the bacterial surface. Theoretical considerations indicate that either complete coverage of the bacterium with PPS or an absence of PPS affinity is a prerequisite for obtaining steric interaction or prevention of bacterial sorption. Experimentally, an absence of PPS affinity (0-0.7 microgram/mg bacteria) was found for bacteria commonly found during cystitis. Immunological treatment of superficial bladder cancer by bacillus Calmette-Guérin (BCG) depends on the interaction of BCG with the bladder wall. Improvement of the treatment may be obtained by increasing BCG adsorption. In this respect, the phenomenon of bridging in which PPS binds simultaneously to both BCG and the bladder-wall surface was investigated. Theoretical considerations and experimental results appeared to be in good agreement. It was found that BCG binds a considerable amount of PPS (3.4 +/- 0.3 microgram/mg BCG). In a guinea pig model the theoretical considerations, indicating the occurrence of bridging at a low and narrow range of PPS concentrations, seemed to be confirmed. In contrast to a high PPS concentration of 10 mg/ml, at a low (0.1 mg/ml) PPS concentration a significant stimulation of the BCG-associated immune reaction(s) was observed. The results suggest that to obtain PPS-induced bridging between BCG and the bladder wall and to prevent steric interaction, PPS should be instilled prior to BCG, separated by extensive washout of free PPS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7516779     DOI: 10.1007/bf00182048

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  38 in total

Review 1.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.

Authors:  R R Isberg; J M Leong
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

Review 3.  An overview of intravesical therapy for superficial bladder tumors.

Authors:  H W Herr; V P Laudone; W F Whitmore
Journal:  J Urol       Date:  1987-12       Impact factor: 7.450

4.  Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.

Authors:  L R Kavoussi; E J Brown; J K Ritchey; T L Ratliff
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Bladder surface glycosaminoglycans: an epithelial permeability barrier.

Authors:  C L Parsons; D Boychuk; S Jones; R Hurst; H Callahan
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

6.  The effects of intravesical pretreatment with pentosan polysulfate on the bacillus Calmette-Guérin induced immune reaction of the guinea pig.

Authors:  T M De Reijke; L C De Boer; P A Steerenberg; P C Vos; K H Kurth; D H Schamhart
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

7.  Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction.

Authors:  R J Garden; B C Liu; S M Redwood; R E Weiss; M J Droller
Journal:  J Urol       Date:  1992-09       Impact factor: 7.450

8.  Mycobacterial adherence and BCG treatment of superficial bladder cancer.

Authors:  D H Schamhart; E C de Boer; R F Bevers; K H Kurth; P A Steerenberg
Journal:  Prog Clin Biol Res       Date:  1992

9.  Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate.

Authors:  C L Parsons
Journal:  J Urol       Date:  1982-01       Impact factor: 7.450

10.  Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.

Authors:  A P van der Meijden; W H de Jong; E C de Boer; P A Steerenberg; F M Debruyne; E J Ruitenberg
Journal:  Urol Res       Date:  1989
View more
  2 in total

1.  In-depth structural characterization of pentosan polysulfate sodium complex drug using orthogonal analytical tools.

Authors:  Anna Alekseeva; Rahul Raman; Giorgio Eisele; Thomas Clark; Adam Fisher; Sau Larry Lee; Xiaohui Jiang; Giangiacomo Torri; Ram Sasisekharan; Sabrina Bertini
Journal:  Carbohydr Polym       Date:  2020-01-27       Impact factor: 9.381

2.  The role of pentosan polysulfate in treatment approaches for interstitial cystitis.

Authors:  Joel Mh Teichman
Journal:  Rev Urol       Date:  2002
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.